Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
18.05
-0.19 (-1.04%)
May 13, 2025, 4:00 PM - Market closed
Beam Therapeutics Market Cap
Beam Therapeutics has a market cap or net worth of $1.76 billion as of May 14, 2025. Its market cap has increased by 2.62% in one year.
Market Cap
1.76B
Enterprise Value
697.80M
1-Year Change
2.62%
Ranking
Category
Stock Price
$18.05
Market Cap Chart
Since February 6, 2020, Beam Therapeutics's market cap has increased from $327.97M to $1.76B, an increase of 436.52%. That is a compound annual growth rate of 37.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2025 | 1.78B | -9.92% |
| Dec 31, 2024 | 1.97B | -8.58% |
| Dec 29, 2023 | 2.16B | -19.78% |
| Dec 30, 2022 | 2.69B | -49.47% |
| Dec 31, 2021 | 5.33B | 15.54% |
| Dec 31, 2020 | 4.61B | 1,305.76% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 669.76B |
| Johnson & Johnson | 357.16B |
| AbbVie | 332.08B |
| Novo Nordisk | 291.59B |
| UnitedHealth Group | 282.47B |
| Abbott Laboratories | 224.53B |
| Novartis AG | 209.81B |
| AstraZeneca | 209.59B |